BR9810739A - Compositions of solubilized sertraline - Google Patents

Compositions of solubilized sertraline

Info

Publication number
BR9810739A
BR9810739A BR9810739-9A BR9810739A BR9810739A BR 9810739 A BR9810739 A BR 9810739A BR 9810739 A BR9810739 A BR 9810739A BR 9810739 A BR9810739 A BR 9810739A
Authority
BR
Brazil
Prior art keywords
compositions
sertraline
solubilized
solubilized sertraline
solubility
Prior art date
Application number
BR9810739-9A
Other languages
Portuguese (pt)
Inventor
Dwayne Thomas Friensen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Productsd Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9810739(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Productsd Inc filed Critical Pfizer Productsd Inc
Publication of BR9810739A publication Critical patent/BR9810739A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

Patente de Invenção: <B>"COMPOSIçõES DE SERTRALINA SOLUBILIZADA"<D>. Composições de matéria que compreendem sertralina e um agente solubilizante que aumenta a solubilidade da sertralina em ambientes de utilização aquosos que contêm íons de cloreto.Invention Patent: <B> "COMPOSITIONS OF SOLUBILIZED SERTRALINE" <D>. Compositions of matter comprising sertraline and a solubilizing agent that increases the solubility of sertraline in aqueous environments containing chloride ions.

BR9810739-9A 1997-07-01 1998-06-15 Compositions of solubilized sertraline BR9810739A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (1)

Publication Number Publication Date
BR9810739A true BR9810739A (en) 2000-09-12

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810739-9A BR9810739A (en) 1997-07-01 1998-06-15 Compositions of solubilized sertraline

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200357A (en) 1999-12-23 2003-10-15 Pfizer Products Inc. Pharmaceutical compositions providing increased concentrations of the drug substance
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP2004507502A (en) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク Sustained release formulation for growth hormone secretagogue
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co Pharmaceutical composition for oral administration
WO2011081117A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (en) * 1989-08-30 1993-11-15 Pfizer USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
SK181099A3 (en) 2000-07-11
KR20010013365A (en) 2001-02-26
AP1192A (en) 2003-07-23
PL337804A1 (en) 2000-09-11
UA67741C2 (en) 2004-07-15
AR015917A1 (en) 2001-05-30
HUP0002236A2 (en) 2003-08-28
CA2290974C (en) 2004-04-27
IL133076A (en) 2003-12-10
ZA985708B (en) 2000-01-10
YU68299A (en) 2002-06-19
NO996520L (en) 2000-02-29
EA199900962A1 (en) 2000-08-28
KR100366373B1 (en) 2003-01-14
PE97199A1 (en) 1999-10-05
IL133076A0 (en) 2001-03-19
CA2290974A1 (en) 1999-01-14
UY25071A1 (en) 2000-12-29
AR040279A2 (en) 2005-03-23
AR040280A2 (en) 2005-03-23
DZ2548A1 (en) 2003-02-08
IS5260A (en) 1999-11-19
WO1999001120A1 (en) 1999-01-14
EP0999829A1 (en) 2000-05-17
NO996520D0 (en) 1999-12-28
HN1998000102A (en) 1999-01-08
TR199903297T2 (en) 2000-07-21
TNSN98124A1 (en) 2005-03-15
EA002481B1 (en) 2002-06-27
CN1261794A (en) 2000-08-02
PA8454301A1 (en) 2000-09-29
TW550087B (en) 2003-09-01
JP2000514100A (en) 2000-10-24
AU7544898A (en) 1999-01-25
AP9801280A0 (en) 1998-06-30
MA24587A1 (en) 1998-12-31
ID23429A (en) 2000-04-20
CO4940495A1 (en) 2000-07-24
HUP0002236A3 (en) 2003-12-29
HRP980377A2 (en) 1999-04-30
AU742535B2 (en) 2002-01-03
OA11243A (en) 2003-07-24

Similar Documents

Publication Publication Date Title
BR9808895A (en) Detergent part
BR0006005A (en) Stable oil composition in glycerinopopically applicable
BR9709048A (en) Information system
HUP9900152A2 (en) Anti-microbial cosmetical composition based on alcohol and its use
MX9603101A (en) Aqueous topical compositions.
DE69935154D1 (en) INHALATION SYSTEM
BR0208543A (en) Packet switched environment
DK1117440T3 (en) Pharmaceutical compositions containing paclitaxel
GB9717905D0 (en) Lipid-containing compositions and uses thereof
BR9913156A (en) Composition and process for conditioning, lightening and enhancing hair
BR0110506A (en) Use of il-18 inhibitors for the treatment and / or prevention of atherosclerosis.
HUP9701611A2 (en) W/o emulsion with a high electrolyte content, and its use in dermo-cosmetics, in particular for treating phenomena of irritation and/or of sensitive skin
BR9810739A (en) Compositions of solubilized sertraline
BR0207654A (en) Composition comprising a base cream or lotion
BR9610930A (en) Depilatory composition including a functional amount of a thixitropic agent, and use of the functional amount of a thixotropic agent.
EP0610010A3 (en) Liquid compositions comprising bleaching and/or hygiene agents of low aqueous solubility.
ATE196992T1 (en) SOLID, NON-DEFLUSABLE FORMULATION OF SODIUM VALPROATE
BR9712993A (en) Oral compositions containing stannous gluconate.
DE975695T1 (en) COMPOSITIONS CONTAINING LUBRICANTS AND ANTIBLOCKING AGENTS
IT1274655B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-INFLAMMATORY AGENT AND AN ANTI-MICROBIAL AGENT
BR0115983A (en) Use of sarp-1 for the treatment and / or prevention of scleroderma.
ATE315629T1 (en) BLEACH COMPOSITIONS
DK1156829T3 (en) Stable formulation containing fumagillin
DE59908266D1 (en) CASE-SAFE SYSTEM
HUP0101455A2 (en) Composition containing stabile antibacterial aromatic carbanilide and process for stabilizing the carbanilide derivative

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.